Rentokil Initial appoints Dr Linda Yueh to its Board as Non-Executive Director

– UK, Camberley – Rentokil Initial plc (LSE: RTO) today announces the appointment of Dr Linda Yueh to its Board as a Non-Executive Director with effect from 1 November 2017. Linda will also become a member of the Audit Committee, the Remuneration Committee and the Nomination Committee from this date.

Linda is Fellow in Economics at St Edmund Hall, Oxford University, and Adjunct Professor of Economics at the London Business School. She is also Visiting Senior Fellow at the London School of Economics and Political Science’s foreign policy think tank, the IDEAS research centre, and was Visiting Professor of Economics at Peking University.

She also serves on the Policy Committee of the Centre for Economic Performance at the London School of Economics, and on the Advisory Board of The Official Monetary and Financial Institutions Forum.

Previously, she has been an advisor to the World Bank, the European Commission, the Asian Development Bank, the World Economic Forum at Davos, and the British Chambers of Commerce, among others. She has served as a Non-Executive Director of the FTSE-listed companies: JPMorgan Asian Investment Trust and Bailie Gifford’s Scottish Mortgage Investment Trust. She spent her early career years as a lawyer in New York with Paul Weiss Rifkind Wharton & Garrison.

Commenting on the appointment, John McAdam, Chairman of Rentokil Initial, said: “Linda has the combination of economic, legal and international experience to bring valuable perspective to the Board and the Company as it continues to grow and develop. I am delighted that she has decided to join us and, along with the rest of the Board, I look forward to working with her.”

For more information : http://www.rentokil-initial.com

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.